Exhibit 31(b)

                         CERTIFICATIONS
                         ______________

I, Edward J. Weisberger, certify that:

  1.    I  have reviewed this quarterly report on Form 10-QSB  of
  IGENE Biotechnology, Inc.;

  2.    Based  on my knowledge, this report does not contain  any
  untrue  statement  of  a  material fact  or  omit  to  state  a
  material  fact necessary to make the statements made, in  light
  of  the  circumstances under which such statements  were  made,
  not  misleading  with  respect to the period  covered  by  this
  report;

  3.    Based  on  my  knowledge, the financial  statements,  and
  other  financial  information included in this  report,  fairly
  present  in  all  material  respects the  financial  condition,
  results  of  operations and cash flows of  the  small  business
  issuer as of, and for, the periods presented in this report;

  4.    The  small business issuer's other certifying  officer(s)
  and   I   are  responsible  for  establishing  and  maintaining
  disclosure controls and procedures (as defined in Exchange  Act
  Rules  13a-15(e)  and 15d-15(e)) for the small business  issuer
  and have:

          (a)  Designed such disclosure controls and  procedures,
          or caused such disclosure controls and procedures to be
          designed under our supervision, to ensure that material
          information  relating  to the  small  business  issuer,
          including its consolidated subsidiaries, is made  known
          to  us  by  others within those entities,  particularly
          during  the  period  in  which  this  report  is  being
          prepared;

          (b)  Evaluated the effectiveness of the small  business
          issuer's   disclosure  controls  and   procedures   and
          presented  in  this  report our conclusions  about  the
          effectiveness   of   the   disclosure   controls    and
          procedures, as of the end of the period covered by this
          report based on such evaluation; and

          (c)  Disclosed in this report any change in  the  small
          business   issuer's  internal  control  over  financial
          reporting  that  occurred  during  the  small  business
          issuer's most recent fiscal quarter (the small business
          issuer's fourth fiscal quarter in the case of an annual
          report)  that has materially affected, or is reasonably
          likely   to  materially  affect,  the  small   business
          issuer's internal control over financial reporting; and

  5.   The  small  business issuer's other certifying  officer(s)
  and  I  have disclosed, based on our most recent evaluation  of
  internal  control  over  financial  reporting,  to  the   small
  business  issuer's  auditors and the  audit  committee  of  the
  small   business  issuer's  board  of  directors  (or   persons
  performing the equivalent functions):

          (a)   All   significant   deficiencies   and   material
          weaknesses  in  the  design or  operation  of  internal
          control  over financial reporting which are  reasonably
          likely  to adversely affect the small business issuer's
          ability  to  record,  process,  summarize  and   report
          financial information; and

          (b)  Any  fraud, whether or not material, that involves
          management  or  other employees who have a  significant
          role  in  the small business issuer's internal  control
          over financial reporting.

Date:  December 11, 2007

/S/ EDWARD J. WEISBERGER
____________________________
    EDWARD J. WEISBERGER
    Chief Financial Officer